Blog

QIAGEN has announced its plans to acquire Parse Biosciences, a rapidly growing company known for its instrument-free single-cell technology.

The ASHG is currently hosting its 2025 Annual Meeting in Boston, the event brings together thousands of scientists, clinicians, and innovators from around the world.

patients with alcohol-associated liver disease have impaired liver regeneration capacity even after cessation of alcohol consumption

scvi-hub is an open repository of pre-trained models for single-cell analysis. It reduces computing and storage costs, facilitates cell annotation and visualization

Single-cell transcriptomics is reshaping microbiome research by moving beyond bulk profiling to capture the activity of individual...

PacBio and EpiCypher announced a strategic alliance within the PacBio Compatible program that incorporates EpiCypher's CUTANA® Hia5 enzyme into PacBio's Fiber-seq assays with HiFi sequencing

ArgenTag is democratizing single-cell sequencing using long-read technology. Its single-cell RNA library kit is compatible with long-read sequencing platforms such as Oxford Nanopore and PacBio.

Thaysen assures that Illumina will achieve solid growth by 2027, driven by its commitment to multiomics and a strategy tailored to researchers.

Clareo Biosciences has partnered with Pacific Biosciences, to leverage the power of long-read sequencing together with Clareo's applied expertise to identify immune signatures and design predictive algorithms to aid in patient diagnosis and stratification.

An international team, including the Max Planck Institute and others, sequenced more than 5,000 malaria parasite genomes in the field using portable Oxford Nanopore devices. This portable method facilitates faster and more accessible malaria surveillance, vital in Africa, where resistance threatens current control programs.

BioSkryb Genomics has obtained an exclusive license to a patent that enables combined DNA methylation and genomic variant analysis in a single cell

Scientists are seeking to decipher the role of non-coding DNA in the human genome, helped by a suite of artificial-intelligence tools.

Single-cell RNA sequencing to identify genes linked to anoikis, a form of programmed cell death critical for preventing tumor spread

The Palo Alto, California-based company, now valued at $120 million, has developed a scalable way to quickly generate crucial biological data needed for AI models–and use them to find new cures for cancer.

Gordon is stepping down as CEO of Oxford Nanopore and is set to leave the post before the end of 2026.

10x Genomics is acquiring Scale Biosciences in a $30M cash-and-stock deal plus milestones.

In the study “ Single cell and spatial alternative splicing analysis with Nanopore long read sequencing ”, published in Nature...

The last August 8th, the Chan Zuckerberg Initiative (CZI) and the Innovative Genomics Institute (IGI) announced the funding of the Center for Pediatric CRISPR Cures (Center).

RAPIDS Single Cell is a new tool that accelerates single-cell data analysis using GPUs. It can process millions of cells in minutes, dramatically reducing time and costs.

The Arc Institute recently launched the Virtual Cell Atlas, a resource of over 300 million cells, and is now partnering with 10x Genomics and Ultima Genomics to make single-cell data collection faster, more scalable, and more affordable, accelerating research aimed at improving human health.